Extracellular vesicle markers in relation to obesity and metabolic complications in patients with manifest cardiovascular disease - Wikidata - awgldk - TriplyDB

Extracellular vesicle markers in relation to obesity and metabolic complications in patients with manifest cardiovascular disease

Extracellular vesicle markers in relation to obesity and metabolic complications in patients with manifest cardiovascular disease

http://www.wikidata.org/entity/Q37568849

about

Should Cell Culture Platforms Move towards EV Therapy Requirements?Structural and functional characterization of endothelial microparticles released by cigarette smoke.Exosomes as the source of biomarkers of metabolic diseases Exosomal miRNAs as potential biomarkers of cardiovascular risk in children.Role of adiponectin and proinflammatory gene expression in adipose tissue chronic inflammation in women with metabolic syndrome Age- and sex-specific differences in blood-borne microvesicles from apparently healthy humans.The Heart Protection Effect of Alcalase Potato Protein Hydrolysate Is through IGF1R-PI3K-Akt Compensatory Reactivation in Aging Rats on High Fat Diets.Minireview: Emerging Roles for Extracellular Vesicles in Diabetes and Related Metabolic Disorders.Diagnostic Value of Cell-free Circulating MicroRNAs for Obesity and Type 2 Diabetes: A Meta-analysis.Impact of diabetes on the predictive value of heart failure biomarkers.Plasma-derived Extracellular Vesicles Contain Predictive Biomarkers and Potential Therapeutic Targets for Myocardial Ischemic (MI) Injury.The diagnostic and prognostic potential of plasma extracellular vesicles for cardiovascular disease.Physiological and pathological impact of exosomes of adipose tissue.The potential of endurance exercise-derived exosomes to treat metabolic diseases.Characterisation of adipocyte-derived extracellular vesicle subtypes identifies distinct protein and lipid signatures for large and small extracellular vesicles.Circulating exosomes in obstructive sleep apnea as phenotypic biomarkers and mechanistic messengers of end-organ morbidity.Extracellular Vesicles from Adipose Tissue-A Potential Role in Obesity and Type 2 Diabetes?Long-term high fat feeding of rats results in increased numbers of circulating microvesicles with pro-inflammatory effects on endothelial cells.Pathological Effects of Exosomes in Mediating Diabetic Cardiomyopathy.Exosomes: Nanocarriers of Biological Messages.Adipose-Derived Exosomes Exert Proatherogenic Effects by Regulating Macrophage Foam Cell Formation and Polarization.Extracellular Vesicles: A Novel Target for Exercise-Mediated Reductions in Type 2 Diabetes and Cardiovascular Disease Risk

P2860

Q26998931-A5B8368A-0B2A-4F0F-966E-CD492F62EDD8 Q27317115-3685FCAF-E880-4542-A8A7-40686990753E Q28069419-FC210AF2-8414-4CEE-A13D-EFDEECA89247 Q33756578-B47B9717-A25D-4E24-BBD9-87BC7F0947FD Q34707943-2D78FBF4-A36F-4B8F-9BC7-0605D077FC4F Q35590638-CB1B13DE-9163-460E-B3A1-3CA0DC20B8C9 Q35723223-C6D17AC6-7448-4DA0-95E4-D5E7DA7E96FE Q36232987-87B4B320-61EB-47D2-80C5-A2FFC750F7AD Q36998610-A6F923BA-067A-4A1D-B891-9B09F38B6323 Q37390778-6771BE01-572B-4530-81B7-9459A84C5E6C Q38392023-AC48FA25-3E81-4C45-928B-72248A0147EC Q38624868-BAF28536-7951-4C60-A64A-AC5AF3735E18 Q38699786-0DCED4E4-6BC7-421A-A696-DE6E7D493280 Q38845636-70BA71F9-3A73-4758-A14A-21DF9F79C744 Q38980177-EA9DCDAD-9330-4E5D-880C-190CCD9CB7E4 Q39413926-2D7AF3EE-38CA-403A-9B5A-850EC0BB6263 Q41463093-41DF1667-B3A8-48A3-B72E-BFCEB1B6D829 Q46742553-B9FC2E54-FBA5-4E4D-902B-654E1818F386 Q47763435-BE73FE79-3956-4F0C-A22D-53F097CBC33E Q47763464-92EFBD6F-6743-4B99-A34E-102D38E5E52A Q52675560-FB5BFBD3-9DF5-42DA-BFB6-B95F544562C8 Q56358143-F83ECD8A-738E-49EF-A21B-8391358DBF42

P2860

Extracellular vesicle markers in relation to obesity and metabolic complications in patients with manifest cardiovascular disease

http://www.wikidata.org/entity/Q37568849

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 05 February 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Extracellular vesicle markers ...... anifest cardiovascular disease

@en

Extracellular vesicle markers ...... nifest cardiovascular disease.

@nl

type

label

Extracellular vesicle markers ...... anifest cardiovascular disease

@en

Extracellular vesicle markers ...... nifest cardiovascular disease.

@nl

prefLabel

Extracellular vesicle markers ...... anifest cardiovascular disease

@en

Extracellular vesicle markers ...... nifest cardiovascular disease.

@nl

P1433

Q37568849-AA698F46-4433-43AD-9F47-69CCC1E6BF77

P1476

Q37568849-D237F947-B242-4221-819E-99D3BCB4DA9E

P2093

Q37568849-043D5018-F78F-4FA4-90CD-1872FDACD00B

Q37568849-19A552BC-B49F-4DDA-B521-34F756B0E27F

Q37568849-1DD1D9F0-2108-4420-A5CF-1CDD943E48A9

Q37568849-2D934FCF-CA54-4143-B91D-9D1AFD6D9009

Q37568849-7A630E49-4B44-481F-96C0-F1567B19636B

Q37568849-906015ED-8F0D-4107-B8CF-A0BD2D9A878E

Q37568849-B07416DC-A041-4187-B607-E32F401F0E10

Q37568849-C7333480-6725-4610-B82E-75106C333AAB

P2860

Q37568849-01EC6450-47FC-44EF-9491-86238A07E443

Q37568849-07CD1B8E-D1DE-4D13-AAAD-4775E8795BF1

Q37568849-0BC0F2E2-19B5-462B-BC98-00C9495F1E5C

Q37568849-1258564F-7E83-4526-940A-118061C315F1

Q37568849-12B8F5C8-612A-4046-8159-3AF16DEC4115

Q37568849-13F17542-26EA-4F19-8357-4901FA178128

Q37568849-1450591F-3951-46B0-A751-9D5C11FCEA20

Q37568849-1B865FEA-E7E5-4834-9AA2-571740F5693D

Q37568849-27C5C582-7D2D-46DF-9DEC-9BA24FB76ABB

Q37568849-29C3415A-5B47-4AE4-BF48-0A6155F50DF5

P2888

Q37568849-65920E89-E205-4A9D-907E-5BADA1D0904F

P304

Q37568849-523176EC-55B4-40ED-AF1C-0D9A2B991E20

P31

Q37568849-B42E2246-CC06-4B24-AA30-DA882CDB9989

P356

Q37568849-D7013708-2314-4D31-AC5A-9314235BE1D9

P407

Q37568849-C2A78A5F-DE2B-478E-8796-6C195694AEFD

P478

Q37568849-19A06F17-CCDA-4ABB-9045-8CE06E0A26AE

P50

Q37568849-045A65DE-40C5-482B-BF53-19E835B96A15

Q37568849-0C57C658-46C5-43E3-9C09-DDED30301F33

Q37568849-3BF8B8B4-61D0-406B-A07C-C87A4056B598

P577

Q37568849-C6E0B1B3-921D-4806-8FA4-718AC1661E6F

P5875

Q37568849-20140852-F70C-4055-A4C6-0A8146CA0AE3

P6179

Q37568849-DFDF66C9-D920-469F-8BCE-FE621505354C

P698

Q37568849-C96B6A47-0E76-4F8A-BA31-55F1067359AA

P921

Q37568849-F485C2EE-3DE9-402B-8056-F8C4B33B3829

Q37568849-FB7A3D40-0438-46AB-8149-E46284967405

P932

Q37568849-D1141CAA-1189-4F8A-9013-41F2917D5052

P356

1475-2840-13-37

P1433

Cardiovascular Diabetology

P1476

Extracellular vesicle markers ...... anifest cardiovascular disease

@en

P2093

Cuno S P M Uiterwaal

http://www.w3.org/2001/XMLSchema#string

Danny A Kanhai

http://www.w3.org/2001/XMLSchema#string

Dominique P V de Kleijn

http://www.w3.org/2001/XMLSchema#string

Eric Kalkhoven

http://www.w3.org/2001/XMLSchema#string

Frank L J Visseren

http://www.w3.org/2001/XMLSchema#string

Mariëtte E G Kranendonk

http://www.w3.org/2001/XMLSchema#string

SMART Study Group

http://www.w3.org/2001/XMLSchema#string

Yolanda van der Graaf

http://www.w3.org/2001/XMLSchema#string

P2860

Overweight, obesity, and elevated serum cystatin C levels in adults in the United States

Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

Structure-function analysis of soluble and membrane-bound CD14

Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study

Membrane vesicles as conveyors of immune responses

Macrophages, inflammation, and insulin resistance

Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition

Long-term prognostic impact of cystatin C on acute coronary syndrome octogenarians with diabetes mellitus.

ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism.

P2888

1475-2840-13-37

P304

37

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1475-2840-13-37

http://www.w3.org/2001/XMLSchema#string

P407

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

SMART Study Group

Gerard Pasterkamp

Dominique P V de Kleijn

P577

2014-02-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

262046437

http://www.w3.org/2001/XMLSchema#string

P6179

1042226041

http://www.w3.org/2001/XMLSchema#string

P698

24498934

http://www.w3.org/2001/XMLSchema#string

P921

cardiovascular disease

P932

3918107

http://www.w3.org/2001/XMLSchema#string